Healthlead Public Company Limited
Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, … Read more
Market Cap & Net Worth: Healthlead Public Company Limited (HL)
Healthlead Public Company Limited (BK:HL) has a market capitalization of $51.10 Million (฿1.77 Billion) as of March 18, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #27018 globally and #448 in its home market, demonstrating a -5.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Healthlead Public Company Limited's stock price ฿6.65 by its total outstanding shares 266476900 (266.48 Million).
Healthlead Public Company Limited Market Cap History: 2021 to 2026
Healthlead Public Company Limited's market capitalization history from 2021 to 2026. Data shows change from $135.07 Million to $51.10 Million (-13.89% CAGR).
Healthlead Public Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Healthlead Public Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Healthlead Public Company Limited's market cap is 0.04 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.00x
Healthlead Public Company Limited's market cap is 1.00 times its annual earnings
9.22x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $135.07 Million | $1.20 Billion | $79.66 Million | 0.11x | 1.70x |
| 2022 | $185.06 Million | $1.52 Billion | $118.23 Million | 0.12x | 1.57x |
| 2023 | $78.83 Million | $1.64 Billion | $74.68 Million | 0.05x | 1.06x |
| 2024 | $78.39 Million | $1.98 Billion | $78.26 Million | 0.04x | 1.00x |
Competitor Companies of HL by Market Capitalization
Companies near Healthlead Public Company Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Healthlead Public Company Limited by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #164 globally with a market cap of $115.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #340 globally with a market cap of $64.39 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #428 globally with a market cap of $51.10 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1455 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | McKesson Corporation | NYSE:MCK | $115.38 Billion | $943.25 |
| #340 | Cencora Inc. | NYSE:COR | $64.39 Billion | $345.88 |
| #428 | Cardinal Health Inc | NYSE:CAH | $51.10 Billion | $217.59 |
| #1455 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Healthlead Public Company Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Healthlead Public Company Limited's market cap moved from $135.07 Million to $ 51.10 Million, with a yearly change of -13.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿51.10 Million | -7.64% |
| 2025 | ฿55.33 Million | -29.41% |
| 2024 | ฿78.39 Million | -0.57% |
| 2023 | ฿78.83 Million | -57.40% |
| 2022 | ฿185.06 Million | +37.01% |
| 2021 | ฿135.07 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Healthlead Public Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $51.10 Million USD |
| MoneyControl | $51.10 Million USD |
| MarketWatch | $51.10 Million USD |
| marketcap.company | $51.10 Million USD |
| Reuters | $51.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.